CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 4 Open-market sale Chief Financial Officer sold 457 shares at $14.71 ($6,723)
- 4 Open-market sale Senior Vice President, R&D sold 1,815 shares at $14.71 ($26,699)
- 4 Open-market sale SVP, GC & Corporate Secretary sold 1,815 shares at $14.71 ($26,699)
- 4 Open-market sale Chief Executive Officer sold 4,455 shares at $14.71 ($65,533)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Acquisition or sale completed
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Other events
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
- 4 Grant or award Director acquired 4,500 shares (grant or award)
Page 21 of 65 · 1,286 filings